Format
Sort by
Items per page

Send to

Choose Destination

Best matches for myasthenia gravis:

Pediatric Myasthenia Gravis. Peragallo JH et al. Semin Pediatr Neurol. (2017)

Myasthenia Gravis. Gilhus NE et al. N Engl J Med. (2016)

Myasthenia gravis: an update for the clinician. Sieb JP et al. Clin Exp Immunol. (2014)

Search results

Items: 1 to 20 of 17214

1.

Cardiac autonomic function evaluation in pediatric and adult patients with congenital myasthenic syndromes.

Günbey C, Sel K, Temuçin ÇM, Aykan HH, Konuşkan B, Karagöz T, Anlar B.

Neuromuscul Disord. 2019 Feb 19. pii: S0960-8966(18)31217-3. doi: 10.1016/j.nmd.2019.02.004. [Epub ahead of print]

PMID:
30898524
2.

Comment on: Thymectomy in patients with myasthenia gravis increases the risk of autoimmune rheumatic diseases: a nationwide cohort study.

Ehrenfeld M, Shoenfeld Y.

Rheumatology (Oxford). 2019 Mar 20. pii: kez093. doi: 10.1093/rheumatology/kez093. [Epub ahead of print] No abstract available.

PMID:
30897627
3.

Repetitive nerve stimulation testing in myasthenic crisis.

Juel VC.

Muscle Nerve. 2019 Mar 21. doi: 10.1002/mus.26472. [Epub ahead of print] No abstract available.

PMID:
30897218
4.

Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy.

Perrinjaquet C, Desbaillets N, Hottinger AF.

Curr Opin Neurol. 2019 Mar 19. doi: 10.1097/WCO.0000000000000686. [Epub ahead of print]

PMID:
30893101
5.

Results of robotic thymectomy performed in myasthenia gravis patients older than 60 years at onset.

Li F, Takahashi R, Bauer G, Yousef MS, Hotter B, Swierzy M, McAleenan A, Ismail M, Meisel A, Rückert JC.

Ann Thorac Surg. 2019 Mar 15. pii: S0003-4975(19)30353-4. doi: 10.1016/j.athoracsur.2019.02.016. [Epub ahead of print]

PMID:
30885848
6.

The placebo response in myasthenia gravis assessed by Quantitative Myasthenia Gravis score: A meta-analysis.

Frisaldi E, Shaibani A, Vollert J, Ferrero B, Carrino R, Ibraheem HD, Vase L, Benedetti F.

Muscle Nerve. 2019 Mar 18. doi: 10.1002/mus.26469. [Epub ahead of print]

PMID:
30883809
7.

MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity.

Huijbers MG, Vergoossen DL, Fillié-Grijpma YE, van Es IE, Koning MT, Slot LM, Veelken H, Plomp JJ, van der Maarel SM, Verschuuren JJ.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 21;6(3):e547. doi: 10.1212/NXI.0000000000000547. eCollection 2019 May.

8.

Using Whole Genome Sequencing in an African Subphenotype of Myasthenia Gravis to Generate a Pathogenetic Hypothesis.

Nel M, Mulder N, Europa TA, Heckmann JM.

Front Genet. 2019 Mar 1;10:136. doi: 10.3389/fgene.2019.00136. eCollection 2019.

9.

Review of paraneoplastic syndromes in children.

Ma GM, Chow JS, Taylor GA.

Pediatr Radiol. 2019 Mar 16. doi: 10.1007/s00247-019-04371-y. [Epub ahead of print] Review.

PMID:
30877339
10.

Application of Plasma Exchange in Steroid-Responsive Encephalopathy.

Jiang Y, Tian X, Gu Y, Li F, Wang X.

Front Immunol. 2019 Feb 27;10:324. doi: 10.3389/fimmu.2019.00324. eCollection 2019. Review.

11.

Association of PTPN22 1858C/T Polymorphism with Autoimmune Diseases: A Systematic Review and Bayesian Approach.

Tizaoui K, Kim SH, Jeong GH, Kronbichler A, Lee KS, Lee KH, Shin JI.

J Clin Med. 2019 Mar 12;8(3). pii: E347. doi: 10.3390/jcm8030347.

12.

Quantification of human neuromuscular function through optogenetics.

Vila OF, Uzel SGM, Ma SP, Williams D, Pak J, Kamm RD, Vunjak-Novakovic G.

Theranostics. 2019 Jan 31;9(5):1232-1246. doi: 10.7150/thno.25735. eCollection 2019.

13.

Non-uremic calciphylaxis in a patient with multiple rheumatologic diseases.

Kusari A, Cotter D, Hinds B, Paravar T.

Dermatol Online J. 2019 Feb 15;25(2). pii: 13030/qt2fg525bs.

14.

Florid T-follicular helper cell hyperplasia associated with extranodal marginal zone lymphoma: a diagnostic pitfall which may mimic T cell lymphoma.

Vroobel KM, O'Connor S, Cunningham D, Wren D, Sharma B, Wotherspoon A, Attygalle AD.

Histopathology. 2019 Mar 12. doi: 10.1111/his.13858. [Epub ahead of print]

PMID:
30860612
15.

Pembrolizumab associated ocular myasthenia gravis.

Liu Q, Ayyappan S, Broad A, Narita A.

Clin Exp Ophthalmol. 2019 Mar 12. doi: 10.1111/ceo.13499. [Epub ahead of print] No abstract available.

PMID:
30859689
16.

Anesthetic considerations for a patient with myasthenia gravis undergoing deep sedation in an outpatient oral surgery setting.

Prabhu SS, Khan SA, Doudnikoff AL, Reebye UN.

J Dent Anesth Pain Med. 2019 Feb;19(1):67-72. doi: 10.17245/jdapm.2019.19.1.67. Epub 2019 Feb 28.

17.

Signs heralding appearance of thymomas after extended thymectomy for myasthenia gravis.

Santos E, Silva AM, Stroebel P, Marinho A, Willcox N, Goncalves G, Lopes C, Marx A, Leite MI.

Neurol Clin Pract. 2019 Feb;9(1):48-52. doi: 10.1212/CPJ.0000000000000551. Review.

PMID:
30859007
18.

Understanding the burden of refractory myasthenia gravis.

Schneider-Gold C, Hagenacker T, Melzer N, Ruck T.

Ther Adv Neurol Disord. 2019 Mar 1;12:1756286419832242. doi: 10.1177/1756286419832242. eCollection 2019. Review.

19.

Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.

Huijbers MG, Plomp JJ, van Es IE, Fillié-Grijpma YE, Kamar-Al Majidi S, Ulrichts P, de Haard H, Hofman E, van der Maarel SM, Verschuuren JJ.

Exp Neurol. 2019 Mar 6;317:133-143. doi: 10.1016/j.expneurol.2019.03.001. [Epub ahead of print]

20.

Biased N-Glycosylation Site Distribution and Acquisition across the Antibody V Region during B Cell Maturation.

Koers J, Derksen NIL, Ooijevaar-de Heer P, Nota B, van de Bovenkamp FS, Vidarsson G, Rispens T.

J Immunol. 2019 Mar 8. pii: ji1801622. doi: 10.4049/jimmunol.1801622. [Epub ahead of print]

PMID:
30850477

Supplemental Content

Loading ...
Support Center